회사 소개
- 법인명: Beijing Kawin Technology Share-Holding Co.,Ltd
- 등록 국가: China
- 주소: No.6 Rongjing East Street, BDA, Beijing, China, Beijing
- 직원 수: 500 - 999
설명:
Focused on viral and immune diseases, Kawin offers mature products built on its specialty in interferon strain management to EP standards, and provides product licensing opportunities including a portfolio of glycyrrhizin products used in dermatology and hepatology, with transfer of interferon and G-CSF (both conventional and pegylated) open to discussion.
사업 활동
바이오의약품
원료의약품 제조업체
바이오의약품 서비스
원료의약품 제조업체
ATC 분류체계 (해부치료화학분류)
원료의약품 제조업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
인증
증거
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기